Improved Diagnostics of Celiac Disease in Children
NCT02072590 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-11-24
Summary
The main purpose of this study is to improve the diagnostics of celiac disease and reduce the need for invasive endoscopic studies in children. Further, the investigators aim to investigate the natural history and risk of complications in children with celiac disease or gluten sensitivity and to create a large scientific database.
Conditions
- Celiac Disease
- Eosinophilic Esophagitis
Sponsors & Collaborators
-
Carol Davila University of Medicine and Pharmacy
collaborator OTHER -
Tampere University Hospital
lead OTHER
Principal Investigators
-
Kalle Kurppa, MD · Tampere Centre for Child Health Research, University of Tampere and Tampere University hospital
Eligibility
- Min Age
- 0 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2023-11-21
- Completion
- 2023-11-21
Countries
- Finland
- Romania
Study Locations
More Related Trials
-
Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife)
NCT06568263 ·Status: RECRUITING
-
Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease
NCT02805816 ·Status: COMPLETED
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Impact of the Diagnosis of Celiac Disease
NCT01145287 ·Status: COMPLETED
-
Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease
NCT05548166 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment of Screen-detected Celiac Disease
NCT01116505 ·Status: COMPLETED ·Phase: NA
-
Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing
NCT02834429 ·Status: COMPLETED
-
Celiac Disease Screening
NCT01902368 ·Status: TERMINATED ·Phase: NA
-
Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease
NCT03321214 ·Status: COMPLETED ·Phase: NA
-
Evidence-based Screening Strategies for Celiac Disease
NCT03136731 ·Status: ENROLLING_BY_INVITATION
-
Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease and Non-celiac Enteropathies
NCT07070596 ·Status: RECRUITING
-
Cytokine Profile in Children With Celiac Disease
NCT02244047 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Preservation of Residual Beta Cell Mass and Prevention of Celiac Disease in Children With Recent Onset Type 1 Diabetes
NCT03037190 ·Status: UNKNOWN ·Phase: NA
-
Entities and Variables Related to Catch-up Growth
NCT06364735 ·Status: RECRUITING
-
Celiac Disease Prevention With Probiotics
NCT03176095 ·Status: COMPLETED ·Phase: NA
-
Celiac Disease Prevention
NCT00617838 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease
NCT02190513 ·Status: COMPLETED
-
Intestinal Fatty Acid-binding Protein (I-FABP) Levels in Pediatric Celiac Patients
NCT03244254 ·Status: UNKNOWN
-
Treatment of Mild Enteropathy Celiac Disease
NCT00628823 ·Status: COMPLETED ·Phase: NA
-
MAgnetic Resonance Imaging in COeliac Disease
NCT02551289 ·Status: COMPLETED
-
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children
NCT04034303 ·Status: UNKNOWN
-
"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease"
NCT06179121 ·Status: ENROLLING_BY_INVITATION
-
Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children
NCT03064997 ·Status: COMPLETED ·Phase: NA
-
Vedolizumab Induction May Prevent Celiac Enteritis
NCT02929316 ·Status: TERMINATED ·Phase: PHASE2
-
Infant Nutrition and Risk of Celiac Disease
NCT00819819 ·Status: TERMINATED ·Phase: NA